Revenue Projection

No one can predict the future, but with the right research and analysis, you can understand the different market scenarios you may face. DeciBio takes a data-driven approach, considering customer demand and preference, product profile, competitive dynamics, regulation, and other market factors to inform your potential revenue scenarios.

Our Experts

David Cavanaugh

David Cavanaugh

Stephane Budel

Miguel Edwards

Schedule a Call

Related Client Results

All Client Results

High-Level Commercial Due Diligence in Digital Pathology

An early-stage venture firm requested a high-level commercial due diligence of a potential investment

Due Diligence

MRD Monitoring Market Assessment and Strategy

A diagnostics player wanted to determine which indications / use cases to target and develop a product road map

Biomarker and Diagnostics Strategy

Go-to-Market

Market Landscaping and Sizing

Cell and Gene Therapy Service Market Opportunity Assessment

A cell and gene therapy services startup wanted to understand how customers could use its cutting-edge technology and which applications to target for further development

Voice-of-Customer Research

Market Landscaping and Sizing

Competitive Analysis

Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to the recent approval of a competing cancer therapy in earlier lines of treatment

Competitive Analysis

Voice-of-Customer Research

Cell Therapy Market Trends and Revenue Forecast

A cell therapy developer preparing for a NASDAQ listing needed financial projections, a valuation, and support on investor messaging

Revenue Projection

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

Biomarker and Diagnostics Strategy

Go-to-Market

Precision Medicine is evolving at a rapid pace

Discover how we can help